🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We have two poster presentations featuring product candidates utilizing our Multivalent Polymer (MVP) technology at the Association for Research in Vision and Ophthalmology Annual Meeting in New Orleans. We hope to see you there in April! #ARVO23 rb.gy/amrbod

As #womenshistorymonth comes to a close, we are reminded that we must continue to recognize and celebrate the vital contributions that women have made towards societal advancement today and every day. interactive.unwomen.org/multimedia/tim…

We have a poster presentation on the potential applications of our multivalent polymer technology in oncology at the 2023 American Association for Cancer Research (#AACR23) Annual Meeting. If you are attending, stop by poster section 14! globenewswire.com/news-release/2…

Over 34 million Americans face hunger each and every day, including 1 in 8 children. During National Volunteer Week, we reflect on our time spent at the Berkeley Food Bank, and the importance of helping where you can. #volunteerweek

We presented exciting preclinical data on our long-acting anti-VEGF biologic in development for durable treatment of wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting in New Orleans. #ARVO23

Today Valitor will be observing Juneteenth to honor the resilience, resistance, and liberation of Black Americans and their contribution to our American Heritage. #Juneteenth2023

This #PRIDE month, join us to celebrate & honor the LGBTQIA+ community by learning more about the impact they’ve had in STEM fields and the ways you can provide a safer work culture for your LGBTQIA+ staff using the resources below. bit.ly/3NmIMuA bit.ly/3Nndfsg

We are delighted to welcome Omkar Joshi to Valitor. He is an experienced technical operations leader with a successful CMC track record and a proven adeptness at building and leading high-performing teams.

We look forward to participating in the UBS Private Company Virtual Symposium on September 20.

We at Valitor wish you a joyous and prosperous New Year!

Valitor is kicking off 2024 at the 42nd Annual J.P. Morgan Healthcare Conference. Steven Lo, CEO, and Wesley Jackson, Ph.D., CSO, will be there to connect with investors and industry contacts. Be sure to say hello!

At #ARVO2024, we will present preclinical data supporting our MVP platform to enable twice-yearly anti-VEGF treatment, which we hope will improve long-term efficacy and reduce clinical costs for treatment of wet age-related macular degeneration (AMD).

President and CSO, Wesley Jackson, Ph.D., will discuss Valitor’s cutting-edge approach to ophthalmology in a presentation and panel discussion at the H.C. Wainwright & Co. 4th Annual Ophthalmology Virtual Conference on Thurs, Aug 15, 2024. Listen here: bit.ly/4dJnDpF

At Valitor, we're committed to innovation and inclusion in every step of our journey. Today we celebrate the numerous, remarkable contributions of women, including those of our colleagues who are driving breakthroughs in healthcare and ophthalmology. #WomensEqualityDay

1 in 3 people over 65 will experience a form of vision loss due to age-related conditions. We’re advancing our MVP technology platform to tackle vision-threatening diseases. While we innovate in the lab, here are resources to reduce the risk of vision loss bit.ly/3ZNlAgC

In honor of #NationalSTEMDay, we’re celebrating the power of STEM education to inspire the next generation of innovators. STEM fuels discoveries that drive new treatments in ophthalmology and beyond. Let’s keep empowering young minds to transform healthcare! #STEMEducation

On this International Day of Women & Girls in Science, we celebrate the women driving biotech innovation. At Valitor, our women scientists are working to improve the lives of patients. Let’s keep breaking barriers & inspiring the next generation! #WomenInScience #GirlsInSTEM

February is AMD & Low Vision Awareness Month. AMD is a leading cause of vision loss in people over 50 and can lead to blindness if untreated. At Valitor, we’re advancing our MVP technology platform to tackle vision-threatening diseases like Wet AMD and protect patients' sight.

President and CSO, Wesley Jackson, Ph.D., will present a company and program overview at Eyecelerator @ Park City 2025 highlighting our groundbreaking MVP technology platform and the potential of our lead development candidate, VLTR-559, to treat wet AMD. bit.ly/44jrJ6M

We are excited to present four posters at #ARVO2025 highlighting the potential of our long-acting anti-VEGF development candidate, VLTR-559, to change the treatment landscape for wet AMD, and the versatility of our groundbreaking MVP technology platform. bit.ly/44jrJ6M